Expression and distribution of vascular endothelial growth factor protein in human brain tumors
about
Clinical presentation, diagnosis, and pharmacotherapy of patients with primary brain tumors.Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomasChemotherapy alleviates subacute recurrent glioma-associated refractory cerebral edema by downregulating vascular endothelial growth factor.The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine.The potential roles of aquaporin 4 in malignant gliomasDoes age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastomaThe significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.Angiogenic factors in the central nervous system.The Quantitative analysis of bFGF and VEGF by ELISA in human meningiomasMolecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.A pilot microdialysis study in brain tumor patients to assess changes in intracerebral cytokine levels after craniotomy and in response to treatment with a targeted anti-cancer agentCytokine and growth factor responses after radiotherapy for localized ependymoma.Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB.miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization StudyCanine astrocytic tumors: a comparative review.Angiogenesis in meningiomas.Antiangiogenic therapy in the management of brain tumors: a clinical overview.Tumor-associated edema in brain cancer patients: pathogenesis and management.Prognostic marker analysis in pediatric intracranial ependymomas.Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis.Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions.Allelic loss but absence of mutations in the polyspecific transporter gene BWR1A on 11p15.5 in hepatoblastoma.Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.Vessel morphometric parameters-correlation with histologic grade and VEGF expression in oligodendroglioma.Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2).Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes.Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to the octreotide treatment.Baseline 11C-methionine PET reflects the natural course of grade 2 oligodendrogliomas.Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.Expression of brain-specific angiogenesis inhibitor 3 (BAI3) in normal brain and implications for BAI3 in ischemia-induced brain angiogenesis and malignant glioma.Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis.Tumor vascular leakiness and blood volume estimates in oligodendrogliomas using perfusion CT: an analysis of perfusion parameters helping further characterize genetic subtypes as well as differentiate from astroglial tumors.Pathogenesis of peri-tumoral edema in intracranial meningiomas.
P2860
Q30581024-78A5B511-938F-4E8F-A4BF-EA505261E7EAQ30992467-F5F640FE-C498-45F5-B4AC-D9F68A10B400Q33388240-9F596405-9723-421A-9B10-C4179DFA8E86Q33415517-0CB12327-696A-44D9-AEFD-B260C625FF3EQ33658672-C73A3EC9-B09F-430E-9ADA-D26E77581C29Q33762106-F37AAFF0-477F-4998-8446-AF3E55A6ABE0Q33868332-6256D888-796E-4E43-B1B8-B7B25B7130F3Q34602545-2434F0D7-88BD-4085-A26F-EEE15DC676C5Q35090526-5EC75948-9B38-41A7-8801-659F0FF570FFQ35207666-D628187A-0FC9-42A3-ABC8-8923B49AEA42Q35598560-20364922-8A97-4306-BC46-9A8F3B791824Q35641225-216AA8ED-8B7E-49E5-8C06-699F0BA62B6AQ35799695-963A77CC-CED7-47DD-8884-A76AAA45DB03Q36090064-B8F4368B-FAC4-404A-90E7-28747460C863Q36525734-4496CA94-4711-42A3-856B-FD38C9958094Q36660822-E9434391-3002-4E75-BE61-2A29EB5CFF5FQ36742601-AC523613-4508-45A9-A92D-D21241388B3AQ37808081-171B7AC1-1245-47DA-BA9F-ECF18EAC4A13Q37835102-5593B954-9341-405D-AF1D-9E2E032118B4Q38028766-6E999132-C20C-4F07-848E-78B2D4F4437EQ38154959-3EB9541B-0A52-4BA9-97D8-B9990AFD7944Q38309196-9BB065CD-03D8-40D3-B1E1-A75E7BC0A356Q38634403-DE950974-68B2-41C2-8010-BBEC4E714E4AQ38929199-02BC4A94-3BDD-4B29-9EE8-32547BB3C71CQ39316156-8126EF2B-3C49-4025-A01C-E854D4CACAAFQ39467094-2EEC051F-ECF5-42DD-A96A-BF449C2A7C54Q40538508-F826B8FE-CE44-4708-98DA-22E4AFAB9DE9Q40753743-9D8DB53B-D36F-43AB-AC21-CDE1D4998249Q41314113-3D10309B-0CCB-4370-9229-BE11C22CA423Q42020014-D4AFC174-9439-4D0A-9057-BB26024A5F5FQ42816271-5E77E826-3BD4-4E84-BF51-039161F20F98Q44610607-AFADDF64-EA83-4B3D-9C2D-27A26F8D1F43Q44813958-D95036BF-AE2F-494D-835B-70D71F784605Q46293733-B69CBD53-ED55-4DA4-8988-12E455F91C95Q46566279-B1DC1BA8-51C0-456B-916F-1A60D5CD7D38Q47249946-822A3714-79BB-45F3-9836-ABB2CD54695AQ47268113-B58DBCC6-AC29-414E-BB02-72A6059D45C9Q47401764-E284AF17-6956-4825-8B6A-1DD20D44E438Q48102344-816BA46A-DEF7-4B8B-8DAF-ECDF997A261AQ48140644-047F7428-9F67-48FD-8491-2E856B71D59B
P2860
Expression and distribution of vascular endothelial growth factor protein in human brain tumors
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Expression and distribution of ...... protein in human brain tumors
@ast
Expression and distribution of ...... protein in human brain tumors
@en
Expression and distribution of ...... protein in human brain tumors
@nl
type
label
Expression and distribution of ...... protein in human brain tumors
@ast
Expression and distribution of ...... protein in human brain tumors
@en
Expression and distribution of ...... protein in human brain tumors
@nl
prefLabel
Expression and distribution of ...... protein in human brain tumors
@ast
Expression and distribution of ...... protein in human brain tumors
@en
Expression and distribution of ...... protein in human brain tumors
@nl
P2093
P356
P1476
Expression and distribution of ...... protein in human brain tumors
@en
P2093
A von Deimling
M M Valter
O D Wiestler
W K Cavenee
P2888
P304
P356
10.1007/S004010050591
P407
P577
1997-02-01T00:00:00Z
P6179
1017261655